| 17alpha-ethynylestradiol | increases expression | ISO | RGD:735385 | 6480464 | Ethinyl Estradiol results in increased expression of LYPLA1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735385 | 6480464 | Tetrachlorodibenzodioxin affects the expression of LYPLA1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735384 | 6480464 | Tetrachlorodibenzodioxin affects the expression of LYPLA1 mRNA | CTD | PMID:22574217 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of LYPLA1 mRNA | CTD | PMID:19162173 |
| 5-fluorouracil | multiple interactions | ISO | RGD:735384 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of LYPLA1 mRNA] | CTD | PMID:15016801 |
| 9-cis-retinoic acid | decreases expression | EXP | | 6480464 | alitretinoin results in decreased expression of LYPLA1 mRNA | CTD | PMID:16648578 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of LYPLA1 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735385 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of LYPLA1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:735385 | 6480464 | Benzo(a)pyrene results in increased expression of LYPLA1 mRNA | CTD | PMID:22228805 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of LYPLA1 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of LYPLA1 promoter | CTD | PMID:22457795 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of LYPLA1 mRNA | CTD | PMID:15913539 |
| calcium atom | multiple interactions | EXP | | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of LYPLA1 mRNA | CTD | PMID:15913539 |
| calcium(0) | multiple interactions | EXP | | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of LYPLA1 mRNA | CTD | PMID:15913539 |
| cisplatin | increases expression | ISO | RGD:735385 | 6480464 | Cisplatin results in increased expression of LYPLA1 mRNA | CTD | PMID:15471895 PMID:15464296 |
| cisplatin | increases expression | ISO | RGD:735385 | 6480464 | Cisplatin results in increased expression of LYPLA1 mRNA | CTD | PMID:15464296 PMID:15471895 |
| clofibrate | decreases expression | ISO | RGD:735385 | 6480464 | Clofibrate results in decreased expression of LYPLA1 mRNA | CTD | PMID:17585979 |
| clofibrate | multiple interactions | ISO | RGD:735385 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of LYPLA1 mRNA; more ... | CTD | PMID:17585979 |
| copper(2+) sulfate | decreases expression | ISO | RGD:735384 | 6480464 | Copper Sulfate results in decreased expression of LYPLA1 mRNA | CTD | PMID:19549813 |
| diarsenic trioxide | decreases expression | ISO | RGD:735384 | 6480464 | arsenic trioxide results in decreased expression of LYPLA1 protein | CTD | PMID:19364129 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of LYPLA1 mRNA | CTD | PMID:21551480 |
| elemental selenium | decreases expression | ISO | RGD:735384 | 6480464 | Selenium results in decreased expression of LYPLA1 mRNA | CTD | PMID:19244175 |
| iron atom | decreases expression | EXP | | 6480464 | Iron deficiency results in decreased expression of LYPLA1 mRNA | CTD | PMID:19821111 |
| lithocholic acid | decreases expression | ISO | RGD:735385 | 6480464 | Lithocholic Acid results in decreased expression of LYPLA1 mRNA | CTD | PMID:20359477 |
| lithocholic acid | multiple interactions | ISO | RGD:735385 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of LYPLA1 mRNA | CTD | PMID:20359477 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of LYPLA1 mRNA | CTD | PMID:20360939 |
| paracetamol | increases expression | ISO | RGD:735385 | 6480464 | Acetaminophen results in increased expression of LYPLA1 mRNA | CTD | PMID:17585979 |
| paracetamol | multiple interactions | ISO | RGD:735385 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LYPLA1 mRNA] | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:735385 | 6480464 | Acetaminophen affects the expression of LYPLA1 mRNA | CTD | PMID:17562736 |
| phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of LYPLA1 mRNA | CTD | PMID:20345932 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:735385 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of LYPLA1 mRNA | CTD | PMID:20359477 |
| selenium atom | decreases expression | ISO | RGD:735384 | 6480464 | Selenium results in decreased expression of LYPLA1 mRNA | CTD | PMID:19244175 |
| tert-butyl hydroperoxide | decreases response to substance | ISO | RGD:735385 | 6480464 | LYPLA1 protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:15003993 |
| undecane | decreases expression | EXP | | 6480464 | undecane results in decreased expression of LYPLA1 protein | CTD | PMID:17337753 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of LYPLA1 mRNA | CTD | PMID:12672911 PMID:15671213 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of LYPLA1 mRNA | CTD | PMID:12672911 PMID:15671213 |